Concepedia

Michael Bobardt

MB

Statistics

Publications

49

Citations

3.2K

H-Index

30

Active since

1989

Affiliations

Scripps Research Institute(Current)

KU Leuven

Debiopharm (Switzerland)

Vlaams Instituut voor Biotechnologie

Rega Institute for Medical Research

Michael Bobardt is an author at Scripps Research Institute specializing in molecular virology, life sciences, and infectious diseases.

ORCID

Publications per year

1989–2023

49

Publications

49

Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on Macrophages

Andrew C. S. Saphire, Michael Bobardt, Zhe Zhang et al. · Journal of Virology · 2001 · 244 citations

, , +16

The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

Robert Flisiak, Andrzej Horban, Philippe Gallay et al. · Hepatology · 2008 · 223 citations

, , +14

Syndecan Captures, Protects, and Transmits HIV to T Lymphocytes

Michael Bobardt, Andrew C. S. Saphire, Hsiu‐Cheng Hung et al. · Immunity · 2003 · 210 citations · Full text

, , +16

The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication

Udayan Chatterji, Michael Bobardt, Suganya Selvarajah et al. · Journal of Biological Chemistry · 2009 · 195 citations · Full text

, , +17

DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A

Lotte Coelmont, Xavier Hanoulle, Udayan Chatterji et al. · PLoS ONE · 2010 · 183 citations · Full text

, , +17

1–5 of 49